SORBISTERIT 15g powder for oral / rectal suspension in sachet medication leaflet

V03AE01 calcium polystyrene sulfonate • Various | All other therapeutic products | Drugs for treatment of hyperkalemia and hyperphosphatemia

Calcium polystyrene sulfonate is used for the treatment of hyperkalemia, a condition characterized by high potassium levels in the blood. This medication works by binding potassium in the intestine and removing it from the body through stool.

It is often used in patients with kidney failure or other conditions that impair the body's ability to eliminate potassium. The medication is available as a powder administered orally or rectally, depending on the severity of hyperkalemia.

Treatment must be carried out under strict medical supervision, as excessive use may lead to electrolyte imbalances, such as hypocalcemia or hypermagnesemia. It is important to monitor potassium levels and other electrolytes during treatment.

Side effects may include nausea, constipation, abdominal discomfort, or, in rare cases, intestinal obstruction. Patients should inform their doctor of any adverse reactions.

General data about SORBISTERIT 15g

Substance: calcium polystyrene sulfonate

Date of last drug list: 01-01-2016

Commercial code: W62039002

Concentration: 15g

Pharmaceutical form: powder for oral / rectal suspension in sachet

Quantity: 90

Product type: generic

Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.

Pharmaceutical forms available for calcium polystyrene sulfonate

Concentrations available for calcium polystyrene sulfonate

15g, 500g